Condition: Atrial Fibrillation (AF) · Sponsor: McMaster University
The purpose of the PAUSE-Virtual Study is to show that by changing pre-surgery visits with patients taking a blood thinner (direct oral anticoagulant (apixaban, dabigatran, edoxaban, rivaroxaban or warfarin) when the participant requires elective surgery, using a standard, in-person proven approach, to a virtual visit, either telephone or video conference, is as safe. Patients who are receiving a blood thinner for the medical condition known as atrial fibrillation (AF) and require an elective surgery/procedure, is common. These patients have to stop taking their blood thinner for a certain time before the procedure to reduce serious complications of stroke or bleeding. For doctors who help manage these patients before a procedure, appointments have been traditionally done in-person. Patients receive instructions about when to stop and restart their blood thinners and taught how to self-administrator a short acting blood thinner (heparin) if needed. The COVID pandemic changed the way these appointments were done, making it important to contact these patients without them having to come to the hospital for an in person visit. Virtual patient care, by telephone or video conference, to communicate to patients about when to start and restart their blood thinner was necessary. This study wants to show that this virtual method of instruction, using a standardized plan of managing patient care, is easy, acceptable to patients and as safe when compared to an in-person meeting. Such in…
This description comes directly from the study's public registry record.
James D Douketis, MD · 905-522-1155 · jdouket@mcmaster.ca
Melanie St John · 905-525-9140 · stjohm1@mcmaster.ca
Always discuss trial participation with your own doctor first.
| Endeavor Health - Northshore | Evanston, Illinois, United States | Recruiting |
| Henry Ford | Detroit, Michigan, United States | Recruiting |
| Northwell Health | Great Neck, New York, United States | Recruiting |
| Thomas Jefferson University Hospital | Philadelphia, Pennsylvania, United States | Recruiting |
| QEII Health Sciences Centre | Halifax, Nova Scotia, Canada | Recruiting |
| Hamilton General Hospital | Hamilton, Ontario, Canada | Recruiting |
| St. Joesph's Healthcare | Hamilton, Ontario, Canada | Recruiting |
| Juravinski | Hamilton, Ontario, Canada | Recruiting |
| The Ottawa Hospital | Ottawa, Ontario, Canada | Recruiting |
| Larissa University Hospital | Larissa, Larisa, Greece | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06844227